Tumour Necrosis Factor – Misnomer and Therapeutic Target
- 1 January 2009
- book chapter
- Published by Springer Nature
- p. 425-448
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- The inhibition of TNF-α anti-tumoral properties by blocking antibodies promotes tumor growth in a rat modelExperimental Cell Research, 2007
- The Inflammatory Cytokine Tumor Necrosis Factor-α Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer CellsCancer Research, 2007
- A small compound that inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 upregulationBiochemical and Biophysical Research Communications, 2005
- The immunology of colorectal cancerSurgical Oncology, 2004
- ThalidomideThe Lancet, 2004
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxinEuropean Journal of Immunology, 1998
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.Journal of Experimental Medicine, 1993
- Heterogeneity of tumour necrosis factor production in renal cell carcinomaEuropean Journal of Cancer, 1992